Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
VERAX BIOMEDICAL via ALSTON & BIRD LLP
2017 · second_quarter · 2T
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
Source: Senate LDA
| ENDO PHARMACEUTICALS |
| 18 |
| 2010–2014 |
| OTP CONSORTIUM | 11 | 2015–2017 |
| JER PARTNERS | 10 | 2007–2010 |
| NOVARTIS CORPORATION | 10 | 2015–2017 |
| HUMACYTE, INC. | 9 | 2015–2017 |
| VERAX BIOMEDICAL | 9 | 2015–2017 |
| INSULET CORPORATION | 7 | 2010–2011 |
| NATIONAL CARDIOVASCULAR PARTNERS | 7 | 2016–2017 |
| PARTNERSHIP FOR QUALITY HOME HEALTHCARE | 6 | 2016–2017 |
| WRIGHT MEDICAL TECHNOLOGY, INC. | 5 | 2009 |
| AMERICAN ASSOCIATION OF HIP AND KNEE SURGEONS | 4 | 2012–2013 |
| CELGENE CORPORATION | 4 | 2014–2015 |
| NATIONAL ASSOCIATION FOR BEHAVIORAL HEALTH | 4 | 2008–2009 |
| COVENANT HEALTHCARE HOSPITAL | 3 | 2008 |
| FUNDAMENTAL HEALTH | 3 | 2008 |
| VISION SERVICE PLAN | 3 | 2009 |
| AIR MEDICAL GROUP HOLDINGS, INC. | 2 | 2009 |
| PROSTRAKAN INC | 2 | 2009 |
| BOEHRINGER INGELHEIM PHARMACEUTICALS INC | 1 | 2008 |
| REHABILITATION INSTITUTE OF CHICAGO | 1 | 2015 |
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
To amend title XVIII of the Social Security Act to provide for direct payment to physician assistants under the Medicare program for certain services furnished by such physician assistants.
Client: FRESENIUS MEDICAL CARE · Firm: ALSTON & BIRD LLP
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
To amend title XVIII of the Social Security Act to provide for direct payment to physician assistants under the Medicare program for certain services furnished by such physician assistants.
Client: KIDNEY CARE COUNCIL · Firm: ALSTON & BIRD LLP
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
To amend title XVIII of the Social Security Act to provide for direct payment to physician assistants under the Medicare program for certain services furnished by such physician assistants.
Client: KIDNEY CARE COUNCIL · Firm: ALSTON & BIRD LLP
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
To amend title XVIII of the Social Security Act to provide for direct payment to physician assistants under the Medicare program for certain services furnished by such physician assistants.
Client: FRESENIUS MEDICAL CARE · Firm: ALSTON & BIRD LLP
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
To amend title XVIII of the Social Security Act to provide for direct payment to physician assistants under the Medicare program for certain services furnished by such physician assistants.
Client: KIDNEY CARE COUNCIL · Firm: ALSTON & BIRD LLP
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
To amend title XVIII of the Social Security Act to provide for direct payment to physician assistants under the Medicare program for certain services furnished by such physician assistants.
Client: KIDNEY CARE COUNCIL · Firm: ALSTON & BIRD LLP
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
American Space Situational Awareness and Framework for Entity Management Act
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
American Space Situational Awareness and Framework for Entity Management Act
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
American Space Situational Awareness and Framework for Entity Management Act
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
American Space Situational Awareness and Framework for Entity Management Act
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Medicare Access and CHIP Reauthorization Act of 2015
Client: HEALTH SOUTH CORPORATION · Firm: ALSTON & BIRD LLP
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Medicare Access and CHIP Reauthorization Act of 2015
Client: HEALTH SOUTH CORPORATION · Firm: ALSTON & BIRD LLP
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: HEALTH SOUTH CORPORATION · Firm: ALSTON & BIRD LLP
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: HEALTH SOUTH CORPORATION · Firm: ALSTON & BIRD LLP
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Sustaining Healthcare Integrity and Fair Treatment Act of 2016
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Sustaining Healthcare Integrity and Fair Treatment Act of 2016
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Sustaining Healthcare Integrity and Fair Treatment Act of 2016
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Sustaining Healthcare Integrity and Fair Treatment Act of 2016
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Comprehensive Addiction and Recovery Act of 2016
Client: OTP CONSORTIUM · Firm: ALSTON & BIRD LLP
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Comprehensive Addiction and Recovery Act of 2016
Client: OTP CONSORTIUM · Firm: ALSTON & BIRD LLP
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Improving Medicare Post-Acute Care Transformation Act of 2014
Client: HEALTH SOUTH CORPORATION · Firm: ALSTON & BIRD LLP
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Improving Medicare Post-Acute Care Transformation Act of 2014
Client: HEALTH SOUTH CORPORATION · Firm: ALSTON & BIRD LLP
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Protecting the Integrity of Medicare Act of 2015
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Affordable Care Act implementation; H.R. 1021, the Protecting Integrity of Medicare Act; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions.
Protecting the Integrity of Medicare Act of 2015
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Affordable Care Act implementation; H.R. 1021, the Protecting Integrity of Medicare Act; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation.
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The ESRD Choice Act (H.R. 5659).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The ESRD Choice Act (H.R. 5659).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The ESRD Choice Act (H.R. 5659).
Medicare Access and CHIP Reauthorization Act of 2015
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions.
Medicare Access and CHIP Reauthorization Act of 2015
Client: HEALTH SOUTH CORPORATION · Firm: ALSTON & BIRD LLP
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015.
Medicare Access and CHIP Reauthorization Act of 2015
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation.
Medicare Access and CHIP Reauthorization Act of 2015
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Affordable Care Act implementation; H.R. 1021, the Protecting Integrity of Medicare Act; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation.
Medicare Access and CHIP Reauthorization Act of 2015
Client: HEALTH SOUTH CORPORATION · Firm: ALSTON & BIRD LLP
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015.
Medicare Access and CHIP Reauthorization Act of 2015
Client: HEALTH SOUTH CORPORATION · Firm: ALSTON & BIRD LLP
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Medicare Access and CHIP Reauthorization Act of 2015
Client: HEALTH SOUTH CORPORATION · Firm: ALSTON & BIRD LLP
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Medicare Access and CHIP Reauthorization Act of 2015
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Affordable Care Act implementation; H.R. 1021, the Protecting Integrity of Medicare Act; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions.
Consolidated Appropriations Act, 2016
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions.
Consolidated Appropriations Act, 2016
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Affordable Care Act implementation; H.R. 1021, the Protecting Integrity of Medicare Act; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions.
Consolidated Appropriations Act, 2016
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Issues relating to home health care and hospice, including post-acute payment policy; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation.
Consolidated Appropriations Act, 2016
Client: NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE · Firm: ALSTON & BIRD LLP
Affordable Care Act implementation; H.R. 1021, the Protecting Integrity of Medicare Act; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation.
Fair Access to Investment Research Act of 2015
Client: OTP CONSORTIUM · Firm: ALSTON & BIRD LLP
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Fair Access to Investment Research Act of 2015
Client: OTP CONSORTIUM · Firm: ALSTON & BIRD LLP
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Fair Access to Investment Research Act of 2015
Client: OTP CONSORTIUM · Firm: ALSTON & BIRD LLP
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Fair Access to Investment Research Act of 2015
Client: OTP CONSORTIUM · Firm: ALSTON & BIRD LLP
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act.
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: PARTNERSHIP FOR QUALITY HOME HEALTHCARE · Firm: ALSTON & BIRD LLP
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: HEALTH SOUTH CORPORATION · Firm: ALSTON & BIRD LLP
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Medicare Post-Acute Care Value-Based Purchasing Act of 2015
Client: HEALTH SOUTH CORPORATION · Firm: ALSTON & BIRD LLP
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Opioid Use Disorder Treatment Expansion and Modernization Act
Client: OTP CONSORTIUM · Firm: ALSTON & BIRD LLP
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Opioid Use Disorder Treatment Expansion and Modernization Act
Client: OTP CONSORTIUM · Firm: ALSTON & BIRD LLP
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Opioid Use Disorder Treatment Expansion and Modernization Act
Client: OTP CONSORTIUM · Firm: ALSTON & BIRD LLP
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
To amend title XVIII of the Social Security Act to establish a demonstration program to provide integrated care for Medicare beneficiaries with end-stage renal disease, and for other purposes.
Client: KIDNEY CARE COUNCIL · Firm: ALSTON & BIRD LLP
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The ESRD Choice Act (H.R. 5659).
To amend title XVIII of the Social Security Act to establish a demonstration program to provide integrated care for Medicare beneficiaries with end-stage renal disease, and for other purposes.
Client: FRESENIUS MEDICAL CARE · Firm: ALSTON & BIRD LLP
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The ESRD Choice Act (H.R. 5659).
To amend title XVIII of the Social Security Act to establish a demonstration program to provide integrated care for Medicare beneficiaries with end-stage renal disease, and for other purposes.
Client: KIDNEY CARE COUNCIL · Firm: ALSTON & BIRD LLP
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
2017 · second_quarter · Q2
Issues regarding group purchasing organizations and delivery reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via ALSTON & BIRD LLP
2017 · second_quarter · 2T
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
OTP CONSORTIUM via ALSTON & BIRD LLP
2017 · second_quarter · 2T
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2017 · second_quarter · Q2
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
NATIONAL CARDIOVASCULAR PARTNERS via ALSTON & BIRD LLP
2017 · second_quarter · 2T
Coverage and payment issues related to outpatient cardiology services; issues related to Regulation No. CMS-156-P, CY 2017, Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates.
Coverage and payment issues related to outpatient cardiology services.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CARE COUNCIL via ALSTON & BIRD LLP
2017 · second_quarter · 2T
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
HUMACYTE, INC. via ALSTON & BIRD LLP
2017 · second_quarter · 2T
Issues related to access to regenerative tissue products; Issues related to improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTH SOUTH CORPORATION via ALSTON & BIRD LLP
2017 · second_quarter · 2T
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2017 · second_quarter · Q2
Issues regarding group purchasing organizations and delivery reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), SENATE, White House Office
FRESENIUS MEDICAL CARE via ALSTON & BIRD LLP
2017 · second_quarter · 2T
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VERAX BIOMEDICAL via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PREMIER, INC. via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Issues regarding group purchasing organizations and delivery reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via ALSTON & BIRD LLP
2017 · first_quarter · Q1
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
OTP CONSORTIUM via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Veterans Affairs, Dept of (VA)
NATIONAL CARDIOVASCULAR PARTNERS via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Coverage and payment issues related to outpatient cardiology services.
Coverage and payment issues related to outpatient cardiology services; issues related to Regulation No. CMS-156-P, CY 2017, Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CARE COUNCIL via ALSTON & BIRD LLP
2017 · first_quarter · Q1
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
HUMACYTE, INC. via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Issues related to access to regenerative tissue products; Issues related to improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTH SOUTH CORPORATION via ALSTON & BIRD LLP
2017 · first_quarter · Q1
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2017 · first_quarter · Q1
Issues regarding group purchasing organizations and delivery reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office
FRESENIUS MEDICAL CARE via ALSTON & BIRD LLP
2017 · first_quarter · Q1
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VERAX BIOMEDICAL via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PREMIER, INC. via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Issues regarding group purchasing organizations and delivery reform; H.R. 6, 21st Century Cures legislation & Senate Companion Bills, including innovation bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB)
OTP CONSORTIUM via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
NATIONAL CARDIOVASCULAR PARTNERS via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Coverage and payment issues related to outpatient cardiology services.
Coverage and payment issues related to outpatient cardiology services; issues related to Regulation No. CMS-156-P, CY 2017, Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CARE COUNCIL via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
HUMACYTE, INC. via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Issues related to access to regenerative tissue products; Issues related to improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTH SOUTH CORPORATION via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
Issues regarding group purchasing organizations and delivery reform; H.R. 6, 21st Century Cures Act and related Senate companion bills, including innovation bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
FRESENIUS MEDICAL CARE via ALSTON & BIRD LLP
2016 · fourth_quarter · Q4
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VERAX BIOMEDICAL via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PREMIER, INC. via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Issues regarding group purchasing organizations and delivery reform; H.R. 6, 21st Century Cures legislation & Senate Companion Bills, including innovation bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via ALSTON & BIRD LLP
2016 · third_quarter · Q3
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016; H.R. 6226 - Pre-Claim Undermines Seniors' Health (PUSH) Act; H.R. 3298 - Medicare Post-Acute Care Value-Based Purchasing Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB)
OTP CONSORTIUM via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
NATIONAL CARDIOVASCULAR PARTNERS via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Coverage and payment issues related to outpatient cardiology services.
Coverage and payment issues related to outpatient cardiology services; issues related to Regulation No. CMS-156-P, CY 2017, Hospital Outpatient PPS Policy Changes and Payment Rates and Ambulatory Surgical Center Payment System Policy Changes and Payment Rates.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
KIDNEY CARE COUNCIL via ALSTON & BIRD LLP
2016 · third_quarter · Q3
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The ESRD Choice Act (H.R. 5659).
HUMACYTE, INC. via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Issues related to access to regenerative tissue products; Issues related to improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTH SOUTH CORPORATION via ALSTON & BIRD LLP
2016 · third_quarter · Q3
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Post-Acute Value-Based Purchasing Act of 2015 (H.R. 3298); PUSH Act of 2016 (H.R.6226); CY 2017 Home Health Prospective Payment System Rate Update; Home Health Value-Based Purchasing Model; and Home Health Quality Reporting Requirements (CMS-1648-P).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2016 · third_quarter · Q3
Issues regarding group purchasing organizations and delivery reform; H.R. 6, 21st Century Cures Act and related Senate companion bills, including innovation bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
FRESENIUS MEDICAL CARE via ALSTON & BIRD LLP
2016 · third_quarter · Q3
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The ESRD Choice Act (H.R. 5659).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VERAX BIOMEDICAL via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Medicare reimbursement issues related to blood products, hospital outpatient prospective payment system.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PREMIER, INC. via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Issues regarding group purchasing organizations and delivery reform; H.R. 6, 21st Century Cures legislation & Senate Companion Bills, including innovation bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via ALSTON & BIRD LLP
2016 · second_quarter · Q2
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016.
CY 2017 Home Health Prospective Payment System Proposed Rule; CMS Pre-Claim Review Demonstration Program; H.R. 5713 - Sustaining Healthcare Integrity and Fair Treatment Act of 2016.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Office of Management & Budget (OMB)
OTP CONSORTIUM via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act. Issues related to S. 524/H.R. 4981, The Comprehensive Addiction and Recovery Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
NATIONAL CARDIOVASCULAR PARTNERS via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Coverage and payment issues related to outpatient cardiology services.
Coverage and payment issues related to outpatient cardiology services.
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Affordable Care Act implementation; H.R. 1021, the Protecting Integrity of Medicare Act; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation.
Issues relating to home health care and hospice, including post-acute payment policy; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions; Issues related to Medicaid Managed Care Regulation.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
KIDNEY CARE COUNCIL via ALSTON & BIRD LLP
2016 · second_quarter · Q2
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
HUMACYTE, INC. via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Issues related to access to regenerative tissue products; Issues related to improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTH SOUTH CORPORATION via ALSTON & BIRD LLP
2016 · second_quarter · Q2
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2016 · second_quarter · Q2
Issues regarding group purchasing organizations and delivery reform; H.R. 6, 21st Century Cures Act and related Senate companion bills, including innovation bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
FRESENIUS MEDICAL CARE via ALSTON & BIRD LLP
2016 · second_quarter · Q2
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PARTNERSHIP FOR QUALITY HOME HEALTHCARE via ALSTON & BIRD LLP
2016 · second_quarter · RR
Issues affecting Medicare-certified home health agencies (HHAs); activities and programs of the Centers for Medicare and Medicaid Services (CMS).
Issues affecting Medicare-certified home health agencies (HHAs); activities and programs of the Centers for Medicare and Medicaid Services (CMS).
VERAX BIOMEDICAL via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Hospital Outpatient Prospective Payment - Proposed Rule and Proposed CY2017 Payment Rates.
Hospital Outpatient Prospective Payment - Proposed Rule and Proposed CY2017 Payment Rates.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
PREMIER, INC. via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Issues regarding group purchasing organizations and delivery reform; 21st Century Cures legislation & Senate Companion Bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
OTP CONSORTIUM via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
NATIONAL CARDIOVASCULAR PARTNERS via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Coverage and payment issues related to outpatient cardiology services.
Coverage and payment issues related to outpatient cardiology services.
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Issues relating to home health care and hospice, including post-acute payment policy; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions.
Affordable Care Act implementation; H.R. 1021, the Protecting Integrity of Medicare Act; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
KIDNEY CARE COUNCIL via ALSTON & BIRD LLP
2016 · first_quarter · Q1
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
HUMACYTE, INC. via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Issues related to access to regenerative tissue products; Issues related to improvements in dialysis care.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTH SOUTH CORPORATION via ALSTON & BIRD LLP
2016 · first_quarter · Q1
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2016 · first_quarter · Q1
Issues regarding group purchasing organizations and delivery reform; H.R. 6, 21st Century Cures Act and related Senate companion bills.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
FRESENIUS MEDICAL CARE via ALSTON & BIRD LLP
2016 · first_quarter · Q1
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL CARDIOVASCULAR PARTNERS via ALSTON & BIRD LLP
2016 · first_quarter · RR
CY 2017 Proposed Hospital Outpatient Department Prospective Payment System/Ambulatory Surgery Center Payment System (HHS/CMS)
CY 2017 Proposed Hospital Outpatient Department Prospective Payment System/Ambulatory Surgery Center Payment System (HHS/CMS)
VERAX BIOMEDICAL via ALSTON & BIRD LLP
2015 · fourth_quarter · Q4
Hospital Outpatient Prospective Payment - Proposed Rule and Proposed CY2016 Payment Rates.
Hospital Outpatient Prospective Payment - Proposed Rule and Proposed CY2016 Payment Rates.
HEALTH SOUTH CORPORATION via ALSTON & BIRD LLP
2015 · fourth_quarter · Q4
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PREMIER, INC. via ALSTON & BIRD LLP
2015 · fourth_quarter · Q4
Issues regarding group purchasing organizations and delivery reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
OTP CONSORTIUM via ALSTON & BIRD LLP
2015 · fourth_quarter · Q4
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2015 · fourth_quarter · Q4
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via ALSTON & BIRD LLP
2015 · fourth_quarter · Q4
Issues relating to home health care and hospice, including post-acute payment policy; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions.
Affordable Care Act implementation; H.R. 1021, the Protecting Integrity of Medicare Act; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Issues related to H.R. 2029, Consolidated Appropriations Act of 2016, Division O, Title V Medicare and Medicaid Provisions.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
KIDNEY CARE COUNCIL via ALSTON & BIRD LLP
2015 · fourth_quarter · Q4
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2016, Final 2016 Letter to Issuers in the Federally-facilitated Marketplaces.
HUMACYTE, INC. via ALSTON & BIRD LLP
2015 · fourth_quarter · Q4
Issues related to access to regenerative tissue products; Issues related to improvements in dialysis care.
Filing targets: HOUSE OF REPRESENTATIVES
GREATER NEW YORK HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2015 · fourth_quarter · Q4
Issues regarding group purchasing organizations and delivery reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
FRESENIUS MEDICAL CARE via ALSTON & BIRD LLP
2015 · fourth_quarter · Q4
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2016, Final 2016 Letter to Issuers in the Federally-facilitated Marketplaces.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
PREMIER, INC. via ALSTON & BIRD LLP
2015 · third_quarter · Q3
Issues regarding group purchasing organizations and delivery reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
KIDNEY CARE COUNCIL via ALSTON & BIRD LLP
2015 · third_quarter · Q3
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2016, Final 2016 Letter to Issuers in the Federally-facilitated Marketplaces.
HEALTH SOUTH CORPORATION via ALSTON & BIRD LLP
2015 · third_quarter · Q3
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015; Medicare Program; Comprehensive Care for Joint Replacement Payment Model for Acute Care Hospitals Furnishing Lower Extremity Joint Replacement Services ([CMS-5516-P]).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via ALSTON & BIRD LLP
2015 · third_quarter · Q3
Affordable Care Act implementation; H.R. 1021, the Protecting Integrity of Medicare Act; H.R. 2, the Medical Access and CHIP Reauthorization Act of 2015.
Issues relating to home health care and hospice, including post-acute payment policy; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
HUMACYTE, INC. via ALSTON & BIRD LLP
2015 · third_quarter · Q3
Issues related to access to regenerative tissue products; Issues related to improvements in dialysis care.
Filing targets: HOUSE OF REPRESENTATIVES
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2015 · third_quarter · Q3
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
OTP CONSORTIUM via ALSTON & BIRD LLP
2015 · third_quarter · Q3
Issues related to S. 1455/H.R. 2356, The Recovery Enhancement for Addiction Treatment (TREAT) Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GREATER NEW YORK HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2015 · third_quarter · Q3
Issues regarding group purchasing organizations and delivery reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
FRESENIUS MEDICAL CARE via ALSTON & BIRD LLP
2015 · third_quarter · Q3
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2016, Final 2016 Letter to Issuers in the Federally-facilitated Marketplaces.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
VERAX BIOMEDICAL via ALSTON & BIRD LLP
2015 · third_quarter · Q3
Hospital Outpatient Prospective Payment - Proposed Rule and Proposed CY2016 Payment Rates.
Hospital Outpatient Prospective Payment - Proposed Rule and Proposed CY2016 Payment Rates.
VERAX BIOMEDICAL via ALSTON & BIRD LLP
2015 · second_quarter · RR
Hospital Outpatient Prospective Payment - Proposed Rule and Proposed CY2016 Payment Rates; lobbying activity to support federal regulatory strategies at CMS and FDA; no specific legislation.
Hospital Outpatient Prospective Payment - Proposed Rule and Proposed CY2016 Payment Rates; lobbying activity to support federal regulatory strategies at CMS and FDA; no specific legislation.
NOVARTIS CORPORATION via ALSTON & BIRD LLP
2015 · second_quarter · Q2
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Issues related to drug coverage and reimbursement.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
OTP CONSORTIUM via ALSTON & BIRD LLP
2015 · second_quarter · Q2
Issues related to S. 1455, the Recovery Enhancement for Addiction Treatment (TREAT) Act.
GREATER NEW YORK HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2015 · second_quarter · Q2
Issues regarding group purchasing organizations and delivery reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
PREMIER, INC. via ALSTON & BIRD LLP
2015 · second_quarter · Q2
Issues regarding group purchasing organizations and delivery reform.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), SENATE, Treasury, Dept of, White House Office
HEALTH SOUTH CORPORATION via ALSTON & BIRD LLP
2015 · second_quarter · Q2
The Budget Control Act of 2011 (P.L. 112-25); The Patient Protection and Affordable Care Act (P.L. 111-148); The Health Care and Education Reconciliation Act of 2010 (P.L. 111-152); The American Taxpayer Relief Act of 2012 (P.L. 112-240); Legislative proposals put forth by the Administration pertaining to rehabilitation hospitals; The Bipartisan Budget Act of 2013; The Pathway for SGR Reform Act of 2013; The Protecting Access to Medicare Act of 2014 (P.L. 113-93); The IMPACT Act of 2014 (H.R. 4994); H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
KIDNEY CARE COUNCIL via ALSTON & BIRD LLP
2015 · second_quarter · Q2
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); Medicare and State Health Care Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute; and Civil Monetary Penalty Rules Regarding Beneficiary Inducements and Gainsharing: Proposed Rule, 79 Fed. Reg. 59717 (Oct. 3, 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2016, Final 2016 Letter to Issuers in the Federally-facilitated Marketplaces.
FRESENIUS MEDICAL CARE via ALSTON & BIRD LLP
2015 · second_quarter · Q2
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F]; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ESRD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458), Patient Protection and Affordable Care Act; HHS Notice of Benefit and Payment Parameters for 2016, Final 2016 Letter to Issuers in the Federally-facilitated Marketplaces.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION FOR HOME CARE AND HOSPICE via ALSTON & BIRD LLP
2015 · second_quarter · Q2
Affordable Care Act implementation; H.R. 1021, the Protecting Integrity of Medicare Act; H.R. 2, the Medical Access and CHIP Reauthorization Act of 2015.
Issues relating to home health care and hospice, including post-acute payment policy; H.R. 2, the Medicare Access and CHIP Reauthorization Act of 2015.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
OTP CONSORTIUM via ALSTON & BIRD LLP
2015 · first_quarter · 1A
Issues related to S. 1455, the Recovery Enhancement for Addiction Treatment (TREAT) Act.
OTP CONSORTIUM via ALSTON & BIRD LLP
2015 · first_quarter · RR
Issues related to S. 1455, the Recovery Enhancement for Addiction Treatment (TREAT) Act.
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The End Stage Renal Disease Choice Act (H.R. 5659); CMS 3337-ATII Medicare Program: Conditions for Coverage for End Stage Renal Disease - Third Party Payment; 21st Century Cures Act (H.R.6).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development); The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces; The Dialysis PATIENT Act (S. 3090, H.R. 5506); The ESRD Choice Act (H.R. 5659).
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2017, Final 2017 Letter to Issuers in the Federally-facilitated Marketplaces.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2016, Final 2016 Letter to Issuers in the Federally-facilitated Marketplaces.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Proposed Rule [CMS-1614-P]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2016, Final 2016 Letter to Issuers in the Federally-facilitated Marketplaces.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
The Protecting Access to Medicare Act of 2014 (Pub. L. 113-93); The Budget Control Act of 2011 (Pub. L. 112-25); The Patient Protection and Affordable Care Act (Pub. L. 111-148); The Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-152); The American Taxpayer Relief Act of 2012 (Pub. L. 112-240); Medicare Program; End-Stage Renal Disease Prospective Payment System, Quality Incentive Program, and Durable Medical Equipment, Prosthetics, Orthotics, and Supplies; Final Rule [CMS-1526-F]; CMS Transmittal 171, CR 8271 Revisions to Medicare Benefit Policy Manual; Centers for Medicare & Medicaid Services, Letter to Issuers on Federally-facilitated Marketplace (Issues related to Marketplace Development), 4 February 2014; Contacted the Center for Consumer Information & Insurance Oversight (CCIIO) relating to Exchange function for individuals with ERSD; The Achieving a Better Life Experience Act of 2014 (ABLE Act of 2014); Medicare and State Health Care Programs: Fraud and Abuse; Revisions to Safe Harbors Under the Anti-Kickback Statute; and Civil Monetary Penalty Rules Regarding Beneficiary Inducements and Gainsharing: Proposed Rule, 79 Fed. Reg. 59717 (Oct. 3, 2014); the Medicare Access and CHIP Reauthorization Act of 2015 (H.R.1458); HHS Notice of Benefit and Payment Parameters for 2016, Final 2016 Letter to Issuers in the Federally-facilitated Marketplaces.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE